Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Stem Cells. 2015 Oct 9;33(12):3655–3665. doi: 10.1002/stem.2215

CHROMATIN REMODELING FACTOR BRG1 SUPPORTS THE EARLY MAINTENANCE AND LATE RESPONSIVENESS OF NESTIN-LINEAGE ADULT NEURAL STEM AND PROGENITOR CELLS

David Petrik 1, Sarah E Latchney 1,*, Irene Masiulis 1,*, Sanghee Yun 1,*, Zilai Zhang 2,*, Jiang I Wu 2,^, Amelia J Eisch 1,^
PMCID: PMC4713255  NIHMSID: NIHMS725788  PMID: 26418130

Abstract

Insights from embryonic development suggest chromatin remodeling is important in adult neural stem cells (aNSCs) maintenance and self-renewal, but this concept has not been fully explored in the adult brain. To assess the role of chromatin remodeling in adult neurogenesis, we inducibly deleted Brg1 – the core subunit of SWI/SNF-like BAF chromatin remodeling complexes – in nestin-expressing aNSCs and their progeny in vivo and in culture. This resulted in abnormal adult neurogenesis in the hippocampus, which initially reduced hippocampal aNSCs and progenitor maintenance, and later reduced its responsiveness to physiological stimulation. Mechanistically, deletion of Brg1 appeared to impair cell cycle progression, which is partially due to elevated p53 pathway and p21 expression. Knockdown of p53 rescued the neurosphere growth defects caused by Brg1 deletion. Our results show that epigenetic chromatin remodeling (via a Brg1 and p53/p21-dependent process) determines the aNSCs and progenitor maintenance and responsiveness of neurogenesis.

Keywords: Neural stem cell, Adult stem cell, Cellular proliferation, Cre-loxP system, Flow cytometry, Epigenetics, Nervous System, Transgenic mouse

INTRODUCTION

Adult neurogenesis in the hippocampal subgranular zone (SGZ) depends on proper proliferation and maintenance of adult neural stem cells (aNSCs) and progenitors to sustain active adult neurogenesis [1]. Understanding the molecular and genetic basis of aNSCs self-renewal and maintenance is an area of great interest [24]. Much is known about how a range of factors influence aNSCs [3, 5], including signaling molecules like Notch1 [6], transcriptional factors like Sox2 [7] and transcriptional repressors such as Bmi1 [8] and NRSF [9]. It is also clear aNSCs are influenced by epigenetic mechanisms [10], including histone modification [11] and non-coding RNAs [12]. Notably, it is not clear how a third group of epigenetic modifications – chromatin remodeling (CR) – influences adult neurogenesis in the hippocampus. This knowledge gap is striking, since ATP-dependent CR complexes (CRC) are critical for many developmental processes [13, 14].

The prototypical ATP-dependent CRC is the SWI/SNF complex, and the functional equivalents in mammals are the BAF (Brg1/Brm-associated factor) complexes [1517]. The core ATPase of the BAF complex is Brg1 (Brm-related gene 1), which acts with 10 other subunits as a CRC to modify DNA accessibility to transcription factors and co-factors [1820]. During embryogenesis, BAF complexes play extensive roles in maintaining stem cell pluripotency, differentiation, and cell survival [21, 22]. As the enzymatic subunit of BAF complexes, Brg1 is particularly critical for BAF complex function. Brg1 knockouts are embryonic lethal [18], and Brg1 is required for embryonic stem cell self-renewal and proliferation [2325]. The molecular mechanisms underlying Brg1’s regulation of cellular processes like proliferation and differentiation are beginning to be understood [21, 26]. However, the role of Brg1 is highly cell- and context-dependent [21, 2630]. Therefore, it will be interesting to determine the specific function of Brg1 in adult neurogenesis. A recent study investigated the role of Brg1 in neurogenesis from the adult subventricular zone (SVZ) and found that Brg1, together with the transcription factor Pax6, directs aNSCs in the SVZ towards neuronal instead oligodendrocyte lineage [31]. Since dramatic changes in fate choice towards oligodendrocyte lineage do not occur in SGZ, it motivated us to consider the possibility that Brg1 may serve dissimilar functions in the adult hippocampus [32].

As the role of BAF complexes in aNSC maintenance and responsiveness to environmental stimuli in the adult hippocampus remains unclear, we inducibly deleted Brg1 in nestin-expressing aNSCs in vivo and in culture. Our results suggest that, similar to embryonic neurogenesis, Brg1 is critical for the proliferation and maintenance of aNSCs and progenitors. Specifically, we show that Brg1 deletion appears to disrupt progression of aNSCs/progenitors. This leads to fewer cells being generated soon after Brg1 deletion. Mechanistically, we show the Brg1 deletion phenotype is dependent on p53-p21 pathways. Brg1 deletion also impairs the neurogenesis response to physiological stimulation. Our results reveal for the first time that chromatin remodeling factor Brg1 supports the early maintenance and late responsiveness of nestin-lineage aNSCs/progenitors in the adult hippocampus.

MATERIALS AND METHODS

Animals

The Institutional Animal Use and Care Committee at UT Southwestern (UTSW) Medical Center approved all experiments in this study. Mice were housed at UTSW in an ALAAC-accredited vivarium. Two different strains of mice were used. For in vivo studies, we generated transgenic mice that allowed temporal and tissue-specific control of Brg1 expression. We crossed nestin-CreERT2/R26R-YFP mice [33] with Brg1flox/flox mice[34] to obtain CreERT2/R26R-YFP/Brg1wt/flox (Ctrl) and CreERT2/R26R-YFP/Brg1flox/flox (iBrg1) mice. Administration of i.p. Tamoxifen (Tam) at around 5 weeks of age induces CreERT2 translocation to the nucleus, which excises exons in Brg1 gene and the stop signal from YFP cassette resulting in Brg1 deletion and YFP expression in nestin-expressing cells and their progeny [33]. In each group and time point, 7–12 mice were used.

For voluntary running, mice were single-housed and allowed 24h access to running wheels (Coulbourn Instruments, Whitehall, PA) for 30 days, with the activity monitored by ClockLab software (ActiMetrics, Wilmette, IL) [6].

For neurosphere experiments, we crossed CAGG-CreER mice[35] with Brg1flox/flox mice[34] to generate Brg1flox/flox and CAGG-CreER/Brg1flox/flox pups. Application of 1 µM 4-hydroxy-Tam (4OH-Tam) to the culture media induced LoxP sites recombination and deletion of Brg1 only in CAGG-CreER/Brg1flox/flox cells. Alternatively, neurospheres cultured from Brg1flox/flox mice were infected with Cre expressing lentiviruses to delete Brg1.

Drug Administration

Adult mice were given Tam (Sigma; 150 mg/kg i.p.) for 5d to induce Cre-mediated recombination [33] and were killed 14, 30, 60 or 90d post-Tam.

Immunohistochemistry

Brains were immersion-fixed (2d) in 4% paraformaldehyde and sunk in 30% sucrose [6, 33]. 30µm coronal sections (entire hippocampus) were cut in serial sets of 9 for stereological evaluation. Slide-mounted or free-floating IHC was performed and immunoreactive(+) SGZ cells were quantified [6, 33]. IHC details, including primary antibodies used, are provided in supplement.

Cell quantification and phenotypic analyses

Quantification of YFP+ SGZ cells was performed stereologically [33, 36]. Confocal phenotyping was performed as described previously [6, 37] and is detailed in the supplement. Unpaired t-test was used for statistical analysis.

Neurosphere assay

Micro-dissected hippocampi from P10 CAGG-CreER/ Brg1flox/flox or Brg1flox/flox pups [9, 38] was dissociated and resulting neurospheres were cultured in non-differentiating media with EGF and FGF [39]. Adult neurospheres were cultured from the SVZ and SGZ areas of P28 CAGG-CreER/ Brg1flox/flox mice. 4OH-Tam was added to induce Brg1 deletion, whereas ETOH solvent was added as controls. After 3 days, spheres were dissociated and cells were counted. The number of cells/well was quantified by hematocytometer or per visual fields as previously described [9]. Additional details provided in supplement.

CFSE dye staining and FACS

Following the last passage, neurospheres were labeled with CFSE dye [40, 41] and treated with 4OH-Tam. Dissociated cells were incubated with anti-CD15 antibody for FACS [42]. CFSE+ live cells were separated from dead cells using standard parameters of forward and side-scattering [43]. CFSE+ live cells were gated into CD15+ and CD15- cells to distinguish neural stem/progenitor vs. differentiated cells. The CD15+ cells were separated into two groups by levels of CFSE fluorescence intensity: low CFSE (1st log decade of CFSE fluorescence scale) and high CFSE (2nd log decade and higher). Additional details provided in supplement.

For cell cycle and cell apoptosis analyses, P10 Brg1flox/flox neurospheres were infected with Cre-expressing lentiviruses or control empty lentiviral vector. After three days, dissociated cells were analyzed with 7AAD for cell cycle and Annexin V for apoptosis using a FACSAria (BD Bioscience).

RT-qPCR

Neurosphere RNA was isolated, cDNA was synthesized, and qPCR was performed using standard approaches as described in Supplemental Information. Results were analyzed following the 2−ΔΔCT method [44] and normalized to expression levels of GAPDH. Primer sequences are provided in the supplement. Unpaired t-tests were used for statistical analysis.

Preparation and infection with lentivirus

Lentiviruses expressing Cre or the control empty pSin vector as well as the p53 shRNA or the PLKO.1 empty shRNA lentiviral vectors were prepared in cultured HEK 293T cells. After 14d (and 3 passages), same number of Brg1flox/flox neurospheres (above) were infected for 24hrs with control virus (PLKO.1 or pSin), p53 shRNA virus, Cre virus, or Cre virus together with p53 shRNA virus. After infection, cells were re-plated in virus-free media, and cell number was quantified 3d later. A parallel experiment with neurospheres utilized standard western blotting techniques to assess levels of Brg1, p53, and GAPDH. Unpaired t-tests were used for statistical analysis. Additional details provided in supplement.

RESULTS

Brg1 deletion in nestin-expressing aNSCs and their progeny initially results in fewer hippocampal aNSCs and progenitor cells

We produced an inducible, conditional knockout of Brg1 in mice by crossing nestin-CreERT2/R26R-YFP mice [33] with Brg1flox/flox mice [34] to obtain CreERT2/R26R-YFP/Brg1wt/flox (control, Ctrl) and CreERT2/R26R-YFP/Brg1flox/flox (iBrg1) mice. Injections of Tamoxifen (Tam, Fig.1A) caused Brg1 deletion and YFP expression only in nestin-expressing aNSCs and their progeny, and YFP-immunoreactive (YFP+) cells were restricted to regions of the adult brain which host aNSCs and adult-generated neurons, such as the hippocampal SGZ (Fig.1B, sFig.1) [45].

Figure 1. Brg1 deletion in nestin-expressing aNSCs and their progeny 14d post-TAM decreases the number of Ki67+DCX+ progenitors in the subgranular zone (SGZ).

Figure 1

(A) Experimental paradigm of giving tamoxifen (Tam) to control (Ctrl) and iBrg1 mice. (B,C) Photomicrographs of Ctrl (B) and iBrg1 (C) mice dentate gyri displaying YFP+ SGZ cells 14d post-Tam (scale bar, sb=50 µm). (D) Quantification of YFP+ SGZ cells 14d post-Tam. (E) Confocal photomicrographs of a Ctrl mouse dentate gyrus 14d post-Tam. Arrowheads: GFAP+Sox2+YFP+ aNSCs with radial glia morphology (sb=20 µm). (F) Confocal phenotyping of YFP+ cells for GFAP+ and Sox2+. (G) Photomicrographs of a Ctrl mouse dentate gyrus 14d post-Tam. Arrowhead: DCX+Ki67+YFP+ cell; Arrows: DCX+YFP+ cells (sb=20 µm). (H) Cell phenotyping of YFP+ cells for DCX+ and Ki67+. (I) Photomicrograph of a Ctrl mouse dentate gyrus 14d post-Tam. Arrowheads: NeuN+YFP+ cells (sb=20 µm). (J) Quantification of NeuN+YFP+ SGZ cells. Data are mean±SEM. Un-paired T-Test (*=p<0.05; #=p<0.1).

Stereological quantification of the number of YFP+ SGZ cells 14 days (14d) post-Tam revealed ~40% fewer cells in iBrg1 vs. Ctrl mice (Fig.1B–D). Confocal phenotypic analysis of the discrete developmental stages of YFP+ cells [6, 46] revealed fewer aNSCs (Type-1; GFAP+Sox2+YFP+) in iBrg1 vs. Ctrl mice (Fig.1E,F) but no change in Sox2+YFP+GFAP- early-stage progenitor cells [7]. Later-stage progenitors/immature neurons appeared unaffected, as there was no difference in doublecortin (DCX)+YFP+Ki67- cell number in iBrg1 vs. Ctrl mice (Fig.1G,H). However, there were fewer DCX+YFP+ cells also positive for the endogenous proliferation marker, Ki67 [47] (Fig. 1G, 1H) in iBrg1 vs. Ctrl mice. This proliferation impairment was restricted to DCX+ cells, as there was no significant difference in Ki67+YFP+DCX- cell number (Fig.1H). While there were fewer aNSCs and progenitors, there was no difference in YFP+NeuN+ mature granule cell number [6, 48] (Fig.1I,J). Thus, at an early timepoint post-Tam, iBrg1 mice have fewer SGZ aNSCs and progenitors, yet produce similar number of adult-generated neurons.

Brg1 deletion reduces number and size of neurospheres in culture

The reduction in aNSCs and progenitors in iBrg1 mice in vivo (Fig.1) suggested altered cell maintenance and/or proliferation. To probe cellular mechanisms of this iBrg1 phenotype, we prepared primary cell cultures of postnatal NSCs using the neurosphere assay. Cells prepared from hippocampi of P10 CAGG-CreER/Brg1flox/flox or Brg1flox/flox mice (Fig.2A–F) were kept in non-differentiating media. After 14d in culture for expansion, cells were exposed to 4OH-Tam to induce Brg1 gene deletion. While neurospheres from both genotypes grew with similar efficiency before 4OH-Tam (Fig.2B,C), deletion of Brg1 in neurospheres derived from CAGG-CreER/Brg1flox/flox mice resulted in fewer neurospheres (Fig.2D) with smaller diameter (Fig.2E) and reduced total cell numbers (Fig.2F) compared to those derived from Brg1flox/flox mice. Neurospheres cultured from SVZ and SGZ of adult (P28) CAGG-CreER/Brg1flox/flox mice displayed similar growth defects after 4OH-Tam induced Brg1 deletion. There is a significant decrease in total cell numbers in 4OH-Tam treated cultures compared to control samples treated with ETOH (sFig. 2A). Thus, Brg1 deletion in vivo (Fig.1) and in culture (Fig.2, sFig.2A) similarly reduces NSCs and the proliferation of their progeny.

Figure 2. Brg1 deletion in postnatal neurospheres reduces number and slows cell division.

Figure 2

(A) Experimental paradigm of neurosphere preparation and gene recombination by 4OH-Tam in culture. (B) Photomicrographs of neurospheres from Brg1flox/flox (B, top) and CreER/Brg1flox/flox (B, bottom) (sb=50 µm). (C) Cell number before 4OH-Tam. (D) Spheres/field during 4OH-Tam. (E) Sphere diameter during 4OH-Tam. (F) Cell number after 4OH-Tam. (G) Experimental paradigm of neurospheres staining with CFSE dye and CD15 antibody for subsequent FACS. (H) Abnormal cell cycle progression/Representative FACS scatterplots of sorted cells showing the CD15+ fluorescence intensity as a function of CFSE fluorescence intensity in Brg-1flox/flox (left) CAGG-CreER/Brg1flox/flox (right). (I) CD15+ cell numbers in the high CFSE fluorescence intensity bracket as a percent of Brg1flox/flox. Data are mean±SEM. Un-paired T-Test (*=p<0.05; **=p<0.01; #=p<0.1). (J) Representative histograms of sorted cells showing cell cycle arrest in Brg1flox/flox neurosphere cells infected with Cre versus control viruses. (K) Representative Annexin V histograms showing increased cell death in Cre virus infected Brg1flox/flox neurosphere cells.

Brg1 deletion appears to impair cell cycle progression in neurospheres

The in vitro and in vivo phenotypes described above could be caused by multiple mechanisms, including slower progression through the cell cycle and/or elevated cell quiescence. To test whether Brg1 deletion reduces number of cell divisions over time, we used fluorescence activated cell sorting (FACS) to analyze neurospheres labeled by CFSE fluorescent dye, in which the fluorescence intensity is reduced by half after each division [41, 49]. The neurospheres were labeled by CFSE just before the addition of 4OH-Tam, and 72hrs later the cells were sorted for CD15, a marker of NSCs [42](Fig.2G–I). Analysis of CFSE fluorescence intensity in CD15+ cells revealed a greater proportion of cells with high CFSE intensity in CAGG-CreER/Brg1flox/flox vs. Brg1flox/flox cells (Fig.2H,I). As CFSE fluorescence is halved with each cell division and thus higher percentage of cells with higher CFSE intensity means fewer cell divisions, these results suggest Brg1 deletion leads to slower cell cycle progression in CD15+ neural stem/progenitor cells.

To directly analyze the effects of Brg1 deletion on cell cycle progression, we performed cell cycle analyses with 7AAD staining of dissociated neurosphere culture to determine the DNA content. Neurospheres cultured from P10 Brg1flox/flox hippocampi were infected with Cre-expressing lentiviruses or empty vectors. Cre-induced Brg1 deletion resulted in increased percentage of cells in G1 phase accompanied with decreased cell numbers in G2/M phase, suggesting a defect in cell cycle progression, likely a G1 arrest (Fig.2J). In addition, Annexin V staining of the same cells indicated that Brg1-deleted sphere cultures have increased apoptosis (Fig. 2K). Taken together, these data suggest the decreased growth of Brg1-deleted neural stem/progenitor cells result from a combination of defected cell cycle progression, fewer cell division, and increased cell death. In vivo, we observed no difference in the number of AC3+ cells in SGZ in both the control and iBrg1 mice (sFig.3), which may be rapidly removed via microglia engulfment [50].

Brg1 deletion results in increased p21 expression in neurospheres

To identify molecular mechanisms responsible for Brg1-induced impairment of cell cycle progression, we explored relative gene expression using RT-qPCR from postnatal neurospheres focusing on genes known to be involved in stem cell regulation[24, 51, 52]. After 72hrs in 4OH-Tam (Fig.3A), there was no difference in CAGG-CreER/Brg1flox/flox vs. Brg1flox/flox cells in expression of stemness gene Cdk6 and Sox2 (Fig.3B). We also investigated the expression of cyclin-dependent kinase inhibitors from the Cip/Kip family that regulate transition from G1 to S-phase [53]. While there was no change in expression of p27 or p57, Brg1 deletion led to increased expression in p21/Cip1/Waf1 in neurospheres cultured from both P10 and P28 brain (Fig. 3B and sFig. 2B).

Figure 3. Brg1 deletion phenotype in postnatal neurospheres is rescued by p53 knockdown.

Figure 3

(A) Experimental paradigm of neurosphere preparation, Cre induction, and RT-qPCR. (B) Comparison of relative gene expression between neurospheres from Brg1flox/flox and CAGG-CreER/Brg1flox/flox mice. (C) Experimental paradigm of lentiviral-mediated expression of Cre and p53 shRNA in P10 neurospheres. (D–G) Photomicrographs of neurospheres 72hrs post-transfection. Neurospheres transfected with control viruses (D), p53 shRNA virus (E), Cre virus (F), and viruses for both Cre and p53 shRNA (G; sb=50 µm). (H) Western blot of P10 neurospheres transfected with control, Cre or Cre + p53 shRNA viruses and stained with antibodies against Brg1, p53 and GAPDH. (I) Quantification of cells 72hrs after viral transfection. Data are mean±SEM. Un-paired T-Test (*=p<0.05).

Knockdown of p53 rescues the Brg1 deletion phenotype in neurospheres

As it has been reported that deleting Brg1 or other BAF subunits in normal cells including specific stem cells may activate p53 pathway and stabilize p53 protein [28, 54, 55], we next explored whether this increase in p21 was related to activation by the tumor suppressor gene p53 [30]. The activations of the p53 pathways by many signals converge to the stabilization of p53 proteins through p53 posttranslational modifications. The activated p53 could interact with transcription co-factors and activate the expression of target genes such as p21 [56]. We tested the connection between Brg1 and p53 in neurosphere cultures using lentiviral delivery of p53 shRNA. We hypothesized that Brg1 deletion activates the p53 pathway by increasing p53 protein levels, and p53 knockdown would rescue the Brg1 deletion phenotype. Because the treatment of 4OH-Tam and viral infection together caused high cellular toxicity (data not shown), we opted for recombination induction by incubating the Brg1flox/flox neurospheres with Cre-expressing lentivirus. In combination with Cre or empty vector control, these Brg1flox/flox neurospheres were co-infected with either PLKO.1 control RNAi lentiviruses or lentiviruses expressing shRNA targeting p53. (Fig.3C–I). Brg1 deletion by viral-mediated Cre expression replicated the phenotype observed after the Brg1 deletion induced by 4OH-Tam (Fig.2F), as there were fewer cells in the Cre vs. control virus infected cultures (Fig.3I). In addition, western blotting of parallel-prepared neurospheres confirmed the viral-mediated efficacy of Brg1 deletion (Fig.3H). Indeed, Brg1 deletion elevated p53 protein levels (Fig.3H). Importantly, although transfection with lentiviral p53 shRNA did not affect cell number in control cells (Fig.3E, 3I), in Brg1 deleted neurospheres, reducing p53 protein levels by p53 shRNA (Fig.3H) restored cell number (Fig.3G, 3I). These data show that knockdown of p53 rescues the Brg1 deletion phenotype, suggesting that elevated p53 pathway may be a mechanism that impairs cell cycle in stem cells lacking Brg1.

Brg1 deletion extends active adult neurogenesis with age

Our results suggest that deletion of Brg1 slows the cell cycle or halts its progression in aNSCs and progenitors. We hypothesized that slower cycle may cause the cells to apparently proliferate less, which may extend their lifespan and consequently augment neurogenesis in later life. To test this, we prepared mice similar to our 14d post-Tam experiment (Fig.1) and examined YFP+ cells 30, 60, and 90d post-Tam (Fig.4A). There was no significant difference in the number of YFP+ cells between Ctrl and iBrg1 mice 30d and 60d post-Tam (data not shown). However, in contrast to the fewer YFP+ SGZ cells seen 14d post-Tam in iBrg1 vs. Ctrl mice (Fig.1), there were no decrease, but a trend towards more YFP+ SGZ cells and more GFAP+Sox2+YFP+ aNSCs 90d post-Tam in iBrg1 vs. Ctrl mice (Fig.4B–E). There was also no change in immature or mature neuron number (Fig.4F–G). These data suggest that there may be altered maintenance of basal adult neurogenesis in iBrg1 mice.

Figure 4. Brg1 deletion 90d post-TAM does not decrease nestin-lineage neurogenesis, but impairs running-induced nestin-lineage neurogenesis.

Figure 4

(A) Experimental paradigm for 90d post-Tam. (B,C) Photomicrographs of YFP+ cells in dentate gyrus of Ctrl (B) and iBrg1 (C) 90d post-Tam (sb=50 µm). (D) Cell quantification and confocal phenotypic analysis in iBrg1 vs. Ctrl mice. (E) Cell phenotyping of YFP+ cells for GFAP+ and Sox2+. (F) Cell phenotyping of YFP+ cells for Ki67+ and DCX+. (G) Cell phenotyping of YFP+ cells for NeuN+. (H) Experimental paradigm for running post-Tam. (I,J) Photomicrographs of dentate gyrus from Ctrl (I) and iBrg1 mice (J) stained for YFP (sb=50 µm). (K,L) Confocal photomicrographs of dentate gyri. (K) Arrow: GFAP+Sox2+YFP+ cells; Open arrowhead: Sox2+YFP+; Closed arrowheads: GFAP+YFP+ cells. (L) Arrowheads: NeuN+YFP+ cells [s.b. (K,L)=20 µm]. (M) YFP+ SGZ cell number in iBrg1 vs. Ctrl mice after running. (N) Cell phenotyping of YFP+ cells for GFAP+ and Sox2+. (O) Cell phenotyping of YFP+ cells for NeuN+. Data are mean±SEM. Un-paired T-Test (*=p<0.05).

Impaired running-induced neurogenesis after Brg1 deletion

One specific feature of hippocampal neurogenesis is the ability to respond to many external stimuli such as exercise. We determined whether YFP+ cells lacking Brg1 may have impaired responsiveness to neurogenic stimuli, such as running [57]. We prepared mice similar to our 14d post-Tam experiment (Fig.1) but gave mice free access to a running wheel 60 to 90d post-Tam (Fig.4H). Cell quantification 90d post-Tam revealed the expected running-induced increase in YFP+ SGZ cells in Ctrl mice (Fig.4D vs. 4M). However, there were significantly more YFP+ cells after running in Ctrl mice vs. iBrg1 mice (Fig.4H–M). Confocal phenotypic analysis further revealed that in the pool of YFP+ cells, there was a trend towards fewer GFAP+Sox2+YFP+ aNSCs and significantly fewer NeuN+YFP+ neurons in iBrg1 vs. Ctrl runners (Fig.4N–O). These results suggest that while running can upregulate adult hippocampal neurogenesis even in iBrg1 mice, this upregulation is less potent than in Ctrl. Taken together, the data in Fig.4 suggest that although Brg1 deletion does not dramatically affect aNSC numbers with age, it impairs the neurogenic responsiveness of these cells to physiological stimulation.

DISCUSSION

The BAF complexes and the core subunit Brg1 regulate many cellular processes, including the cell cycle progression [13]. From studies in vivo and in cultured malignant and non-malignant cells [28], it is clear that Brg1 regulates the cell cycle via diverse mechanisms and in a context-dependent manner. A recent report on Brg1 function in adult SVZ neurogenesis revealed a critical role of Brg1 in neuronal fate specification by cooperating with PAX6 [31]. However, it remains unclear whether Brg1 affect neural stem cell maintenance and responsiveness to environmental stimuli in the adult hippocampus. Here we addressed this major knowledge gap, and our findings suggest that Brg1 supports the early maintenance and late responsiveness of nestin-lineage aNSC/progenitors without dramatically altering the fate choice. We show that acute Brg1 deletion in nestin-lineage cells leads to fewer aNSC/progenitors, perhaps due to a slower cell cycle caused by activated p53/p21 pathway. Brg1 deletion also leads to impaired response to neurogenic stimulation. Together these data show for the first time the integral role that CRC play in regulating neurogenesis in the adult hippocampus. Below we discuss our three major findings, and how these data influence our understanding of the regulation of adult hippocampal neurogenesis by CRCs.

p53/p21 activation contributes to stem cell maintenance defects caused by Brg1 deletion

Various embryonic stem and progenitor cells lacking Brg1 have impaired proliferation, arrest, and cell death [13, 21]. Similarly, here we show aNSCs lacking Brg1 have impaired maintenance and slowed cell cycle. However, BAF complexes are not likely essential for cell proliferation or survival per se, since many cancer cells lack different BAF subunits and yet display extensive proliferation capacity [5860]. Thus a puzzling paradox persists: removal of a tumor suppressor like Brg1 actually decreased proliferation of stem cells.

One possible explanation is that deletion of Brg1 triggers the activation of cell surveillance pathways and causes cell cycle arrest and increased quiescence indirectly. Indeed, p53 is activated after loss of Brg1 or another BAF complex subunit, SNF5, in MEF cells and specific cancer cells [28, 55]. In human bone marrow mesenchyme stem cells, Brg1 deletion leads to senescence through the activation of RB-p53 pathways. These reports agree with our present results, where Brg1 deletion in hippocampal neural stem cells increased p53 protein levels and p53 target genes are upregulated. Our present work further confirms this Brg1/p53 link in stem cells, as knockdown of p53 in neurospheres lacking Brg1 rescues the reduction in cell number. The link between Brg1 and p53/p21 in regulating stem cells is plausible, as loss of p21 reduces the quiescence and accelerates the exhaustion of aNSC proliferative capacity [61]. Moreover, loss of p53 in aNSCs leads to increased proliferation and dramatically reduced levels of p21 [62], while increased p53 activity reduces proliferation[63, 64]. Since our results show that Brg1 deletion increases p53 protein and p21 expression in neurospheres, we speculate that iBrg1 stem cells in vivo have increased cell quiescence. It is also possible that p53 protein is stabilized following Brg1 deletion [28, 55], or there exists p53 post-transcriptional regulatory mechanisms [56]. Given the challenges of visualizing increases in p53+ or p21+ cells in the healthy adult mouse hippocampus [65, 66], this hypothesis is ripe for testing using other approaches, such as cell cycle reporter mice [67, 68].

Impaired cell maintenance and quiescence caused by Brg1 deletion is part of a multilayered phenotype

The function of Brg1 in aNSC/progenitors is likely to be multilayered, because Brg1 regulates not only stem cell self-renewal and maintenance [2325] but also differentiation and maturation of neurons [31, 69]. Several aspects of our data support the notion of a complex, multilayered phenotype in the SGZ of iBrg1 mice. First, in addition to iBrg1 mice having fewer aNSCs and progenitors, they also have fewer proliferating Ki67+DCX+ neuroblasts. Second, iBrg1 mice display no difference in the basal number of YFP+ mature neurons either early or late after Tam-induced recombination. This multilayered phenotype suggests a compensatory mechanism in maturation or survival of YFP+ neurons, which may also explain the diminishment of the phenotype at late post-Tam.

The lack of change in mature neurons at early or late post-Tam deserves further discussion. We interpret our data from the early post-Tam timepoint (Fig.1) as indication that Brg1 deletion in nestin-expressing aNSCs and their progeny initially results in fewer hippocampal aNSCs and progenitor cells, but does not change the number of adult-generated granule cell neurons. This timepoint may seem too early to assess differentiation, as it is widely stated that it takes ~30 days for an adult-generated hippocampal neuron to achieve terminal differentiation and thus express proteins like NeuN [1, 46]. However, numerous publications show mature neuron protein expression much sooner than 30 days [48, 70]. In fact, NeuN expression can be detected as early as a few days after division [38]. Therefore, we feel our interpretation remains valid: Brg1 deletion in nestin-expressing aNSCs and their progeny initially decreased the number of hippocampal aNSCs and progenitor cells without changing adult-generated granule cell neuron number. However, we do not know if the terminal differentiation of adult-born neurons is affected at intermediate timepoints between 14 and 90 days post-Tam. While our late post-Tam timepoint shows that terminal differentiation of adult-born neurons is not affected (Fig. 4G), this lack of change may reflect a compensatory mechanism in maturation or survival of YFP+ neurons, as a lower number of aNSCs and progenitors still produce similar number of neurons in both iBrg1 and Ctrl SGZ. It is interesting, though, that when exposed to a proneurogenic stimuli such as running [57] the terminal differentiation of adult-generated neurons is actually decreased (Fig. 4O). This suggests that terminal differentiation may be vulnerable under certain physiological or pathological conditions.

The initial reduction in number of aNSC/progenitors early after Brg1 deletion was observed both in vivo and in culture, suggesting a cell-intrinsic effect. We cannot exclude the possibility that the initial decrease in aNSCs and progenitors after Brg1 deletion is not just due to slower progression through cell cycle or increased cell quiescence but also due to reduced number of proliferating cells or increased cell death. However, we did not observe a change in number of Ki67+YFP+ cells at 14d post-Tam, suggesting no change in proliferation per se.

It is also important to consider that recombination efficiency (or lack thereof) is an important issue in inducible transgenic mouse models. Some of our results may be complicated by limited recombination efficiency of Brg1 in our inducible mouse model. However, determining recombination efficiency in our iBrg1 mice is challenging since Brg1 expression in aNSC is relatively low and it is difficult to distinguish it from the highly similar homolog Brm (75% identical at the protein level). We do provide evidence of a greater proportion of YFP+ cells that were Brg1- in iBrg1 vs. control mice (sFig.1). More compellingly, most of these Brg1- cells were NSC-like, Type-1, or Type-2 cells, fitting with our concept that Brg1 expression are higher in mature YFP+ neurons than in Type-1 or Type-2 progenitors.

aNSC/progenitors lacking Brg1 are less responsive to physiological stimuli with age

The third major finding presented here is the mitigation of the KO phenotype with time. The reduction in neurogenesis in iBrg1 KO mice 14d post Tam is replaced by a trend towards increased neurogenesis at 90 days. While we recognize that this switch may be partially a consequence of incomplete deletion of Brg1 in the recombined population, we suggest that the trend towards the increase in number of hippocampal aNSC/progenitors in iBrg1 mice over time is a paradoxical consequence of their initial decrease. Our in vitro results show that neurospheres lacking Brg1 progress through cell cycle slower, which would extend their active lifespan if aNSCs have a limited number of cell divisions [4]. Alternatively, Brg1 deletion would increase stem cell quiescence as a consequence of increased p21 expression [61] leading to extended lifespan of aNSCs.

Interestingly, while there may be unaltered or even increased neurogenesis in aged iBrg1 KO animals, their YFP+ population in SGZ is less responsive to environmental and physiological stimuli such as running [57]. This suggests that although impact of Brg1 deletion in aNSCs and their progeny may be compensated with age, the responsiveness of the aNSCs and progenitors in aged KO animals is impaired. Since running increases hippocampal adult neurogenesis mainly via promoting proliferation [57, 71, 72], we may speculate that cells lacking Brg1 are either less likely to be activated or the number and cell cycle progression may be affected.

In summary, our results not only reveal the importance of Brg1 for proliferation and maintenance of aNSCs and progenitors in adult hippocampus but also highlight the innate differences between the two adult neurogenic niches. Deletion of Brg1 driven by Nestin-CreERT2 leads to different consequences in the lateral ventricles versus in adult hippocampus. In SVZ, Brg1 coordinates with Pax6 to keep the aNSCs and their progeny in the neurogenic lineage [31], which is important for the Type B aNSCs SVZ because they have strong multipotency and can generate both glia and neurons [73, 74]. The limited multipotency of Type-1 aNSCs in adult hippocampus directs them towards generating neurons [4] and thus Brg1 seems to assume a different role in their biology, regulation of proliferation and maintenance of aNSCs and their progeny. The differential development of the Brg1 KO phenotype in SGZ and SVZ also underlines the differences in cellular dynamics between the two neurogenic niches with respect to epigenetic regulation by CRC complexes and the ability to compensate impaired neurogenesis [57]. This supports the idea that the proliferative potential of aNSC/progenitors that lack Brg1 is altered in time, and that their responsiveness to physiological stimuli is restricted.

Supplementary Material

Supp FigureS1-S3 & TableS1-S3
Supp MaterialS1

Significance Statement.

Our result reveal the importance of a chromatin remodeling factor, Brg1, in regulation of stem and other dividing cells in the hippocampus, a region in the adult brain important for memory and mood regulation. Notably, although new neurons are generated in the hippocampus and another brain region, termed the SVZ, Brg1 has a distinct role in the hippocampus than has been shown in the SVZ. This work is significant in its advancement of our understanding of how stem and dividing cells are regulated in the body, and these findings have relevance for understanding brain structure and function in regards to development as well as in the adult brain.

ACKNOWLEDGEMENTS

GRANT SUPPORT

This work was supported to by grants to AJE from the NIH (DA02355, DA016765, MH107945), NASA (NNX12AB55G, NNX15AE09G), and a NARSAD Independent Investigator Grant from the Brain and Behavior Foundation, and by grants to JW from the Whitehall Foundation, Welch Foundation, and NIH (MH102820). IM and SEL were supported by T32DA007290, PI AJE. SY was supported by T32MH076690, PI Carol A. Tamminga.

The authors thank Yu Chen for excellent technical assistance, Xiaoming Zhan and Xuanming Shi for fruitful discussions, Ming Zeng, Zhigang Lu and Junke Zheng for their expert guidance in the FACS experiments, and Wei Mo for providing reagents.

Footnotes

AUTHOR CONTRIBUTIONS

David Petrik: Conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of manuscript

Sarah E. Latchney: Collection and/or assembly of data, data analysis and/or interpretation, manuscript writing, final approval of manuscript

Irene Masiulis: Collection and/or assembly of data, data analysis and/or interpretation, manuscript writing, final approval of manuscript

Sanghee Yun: Collection and/or assembly of data, data analysis and/or interpretation, manuscript writing, final approval of manuscript

Zilai Zhang: Collection and/or assembly of data, data analysis and/or interpretation, manuscript writing, final approval of manuscript

Jiang I. Wu: Conception and design, financial support, provision of study material or patients, data analysis and/or interpretation, manuscript writing, final approval of manuscript

Amelia J. Eisch: Conception and design, financial support, provision of study material or patients, data analysis and/or interpretation, manuscript writing, final approval of manuscript

REFERENCES

  • 1.Ming GL, Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron. 2011;70(4):687–702. doi: 10.1016/j.neuron.2011.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bonaguidi MA, Wheeler MA, Shapiro JS, et al. In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics. Cell. 2011;145(7):1142–1155. doi: 10.1016/j.cell.2011.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kempermann G. The pessimist's and optimist's views of adult neurogenesis. Cell. 2011;145(7):1009–1011. doi: 10.1016/j.cell.2011.06.011. [DOI] [PubMed] [Google Scholar]
  • 4.Encinas JM, Michurina TV, Peunova N, et al. Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus. Cell Stem Cell. 2011;8(5):566–579. doi: 10.1016/j.stem.2011.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lugert S, Basak O, Knuckles P, et al. Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging. Cell Stem Cell. 2010;6(5):445–456. doi: 10.1016/j.stem.2010.03.017. [DOI] [PubMed] [Google Scholar]
  • 6.Ables JL, Decarolis NA, Johnson MA, et al. Notch1 is required for maintenance of the reservoir of adult hippocampal stem cells. J Neurosci. 2010;30(31):10484–10492. doi: 10.1523/JNEUROSCI.4721-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Suh H, Consiglio A, Ray J, et al. In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell. 2007;1(5):515–528. doi: 10.1016/j.stem.2007.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Molofsky AV, Pardal R, Iwashita T, et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003;425(6961):962–967. doi: 10.1038/nature02060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gao Z, Ure K, Ding P, et al. The master negative regulator REST/NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells. J Neurosci. 2011;31(26):9772–9786. doi: 10.1523/JNEUROSCI.1604-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hsieh J, Eisch AJ. Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind. Neurobiol Dis. 2010;39(1):73–84. doi: 10.1016/j.nbd.2010.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lim DA, Huang YC, Swigut T, et al. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature. 2009;458(7237):529–533. doi: 10.1038/nature07726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liu C, Teng ZQ, Santistevan NJ, et al. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell. 2010;6(5):433–444. doi: 10.1016/j.stem.2010.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hargreaves DC, Crabtree GR. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res. 2011;21(3):396–420. doi: 10.1038/cr.2011.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Son EY, Crabtree GR. The role of BAF (mSWI/SNF) complexes in mammalian neural development. Am J Med Genet C Semin Med Genet. 2014;166C(3):333–349. doi: 10.1002/ajmg.c.31416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Khavari PA, Peterson CL, Tamkun JW, et al. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature. 1993;366(6451):170–174. doi: 10.1038/366170a0. [DOI] [PubMed] [Google Scholar]
  • 16.Wang W, Cote J, Xue Y, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 1996;15(19):5370–5382. [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhao K, Wang W, Rando OJ, et al. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell. 1998;95(5):625–636. doi: 10.1016/s0092-8674(00)81633-5. [DOI] [PubMed] [Google Scholar]
  • 18.Bultman S, Gebuhr T, Yee D, et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell. 2000;6(6):1287–1295. doi: 10.1016/s1097-2765(00)00127-1. [DOI] [PubMed] [Google Scholar]
  • 19.Cairns BR. Chromatin remodeling: insights and intrigue from single-molecule studies. Nat Struct Mol Biol. 2007;14(11):989–996. doi: 10.1038/nsmb1333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wu JI, Lessard J, Crabtree GR. Understanding the words of chromatin regulation. Cell. 2009;136(2):200–206. doi: 10.1016/j.cell.2009.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wu JI. Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer. Acta Biochim Biophys Sin (Shanghai) 2012;44(1):54–69. doi: 10.1093/abbs/gmr099. [DOI] [PubMed] [Google Scholar]
  • 22.Lessard JA, Crabtree GR. Chromatin regulatory mechanisms in pluripotency. Annu Rev Cell Dev Biol. 2010;26:503–532. doi: 10.1146/annurev-cellbio-051809-102012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Matsumoto S, Banine F, Struve J, et al. Brg1 is required for murine neural stem cell maintenance and gliogenesis. Developmental Biology. 2006;289(2):372–383. doi: 10.1016/j.ydbio.2005.10.044. [DOI] [PubMed] [Google Scholar]
  • 24.Ho L, Jothi R, Ronan JL, et al. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A. 2009;106(13):5187–5191. doi: 10.1073/pnas.0812888106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lessard J, Wu JI, Ranish JA, et al. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron. 2007;55(2):201–215. doi: 10.1016/j.neuron.2007.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lee D, Kim JW, Seo T, et al. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem. 2002;277(25):22330–22337. doi: 10.1074/jbc.M111987200. [DOI] [PubMed] [Google Scholar]
  • 27.Xu Y, Zhang J, Chen X. The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes. J Biol Chem. 2007;282(52):37429–37435. doi: 10.1074/jbc.M706039200. [DOI] [PubMed] [Google Scholar]
  • 28.Naidu SR, Love IM, Imbalzano AN, et al. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene. 2009;28(27):2492–2501. doi: 10.1038/onc.2009.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hsu CC, Lee YC, Yeh SH, et al. 58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathway. J Biol Chem. 2012;287(27):22533–22548. doi: 10.1074/jbc.M111.335331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Harms K, Nozell S, Chen X. The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci. 2004;61(7–8):822–842. doi: 10.1007/s00018-003-3304-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ninkovic J, Steiner-Mezzadri A, Jawerka M, et al. The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network. Cell Stem Cell. 2013;13(4):403–418. doi: 10.1016/j.stem.2013.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Imayoshi I, Sakamoto M, Ohtsuka T, et al. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain. Nat Neurosci. 2008;11(10):1153–1161. doi: 10.1038/nn.2185. [DOI] [PubMed] [Google Scholar]
  • 33.Lagace DC, Whitman MC, Noonan MA, et al. Dynamic contribution of nestin-expressing stem cells to adult neurogenesis. J Neurosci. 2007;27(46):12623–12629. doi: 10.1523/JNEUROSCI.3812-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sumi-Ichinose C, Ichinose H, Metzger D, et al. SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells. Mol Cell Biol. 1997;17(10):5976–5986. doi: 10.1128/mcb.17.10.5976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol. 2002;244(2):305–318. doi: 10.1006/dbio.2002.0597. [DOI] [PubMed] [Google Scholar]
  • 36.Lagace DC, Donovan MH, DeCarolis NA, et al. Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance. Proc Natl Acad Sci U S A. 2010;107(9):4436–4441. doi: 10.1073/pnas.0910072107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Arguello AA, Fischer SJ, Schonborn JR, et al. Effect of chronic morphine on the dentate gyrus neurogenic microenvironment. Neuroscience. 2009;159(3):1003–1010. doi: 10.1016/j.neuroscience.2009.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255(5052):1707–1710. doi: 10.1126/science.1553558. [DOI] [PubMed] [Google Scholar]
  • 39.Kapoor R, Desouza LA, Nanavaty IN, et al. Thyroid hormone accelerates the differentiation of adult hippocampal progenitors. J Neuroendocrinol. 2012;24(9):1259–1271. doi: 10.1111/j.1365-2826.2012.02329.x. [DOI] [PubMed] [Google Scholar]
  • 40.Parish CR. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol Cell Biol. 1999;77(6):499–508. doi: 10.1046/j.1440-1711.1999.00877.x. [DOI] [PubMed] [Google Scholar]
  • 41.Deleyrolle LP, Rohaus MR, Fortin JM, et al. Identification and isolation of slow-dividing cells in human glioblastoma using carboxy fluorescein succinimidyl ester (CFSE) J Vis Exp. 2012;(62) doi: 10.3791/3918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron. 2002;35(5):865–875. doi: 10.1016/s0896-6273(02)00835-8. [DOI] [PubMed] [Google Scholar]
  • 43.Gilley JA, Yang CP, Kernie SG. Developmental profiling of postnatal dentate gyrus progenitors provides evidence for dynamic cell-autonomous regulation. Hippocampus. 2011;21(1):33–47. doi: 10.1002/hipo.20719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 45.Sun MY, Yetman MJ, Lee TC, et al. Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin-CreER(T2) lines. J Comp Neurol. 2014;522(5):1191–1208. doi: 10.1002/cne.23497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kempermann G, Jessberger S, Steiner B, et al. Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 2004;27(8):447–452. doi: 10.1016/j.tins.2004.05.013. [DOI] [PubMed] [Google Scholar]
  • 47.Arguello AA, Harburg GC, Schonborn JR, et al. Time course of morphine’s effects on adult hippocampal subgranular zone reveals preferential inhibition of cells in S phase of the cell cycle and a subpopulation of immature neurons. Neuroscience. 2008;157(1):70–79. doi: 10.1016/j.neuroscience.2008.08.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Brown JP, Couillard-Despres S, Cooper-Kuhn CM, et al. Transient expression of doublecortin during adult neurogenesis. J Comp Neurol. 2003;467(1):1–10. doi: 10.1002/cne.10874. [DOI] [PubMed] [Google Scholar]
  • 49.Groszer M, Erickson R, Scripture-Adams DD, et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science. 2001;294(5549):2186–2189. doi: 10.1126/science.1065518. [DOI] [PubMed] [Google Scholar]
  • 50.Sierra A, Encinas JM, Deudero JJ, et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell. 2010;7(4):483–495. doi: 10.1016/j.stem.2010.08.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Paik JH, Ding Z, Narurkar R, et al. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell. 2009;5(5):540–553. doi: 10.1016/j.stem.2009.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Zhang X, Yalcin S, Lee DF, et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol. 2011;13(9):1092–1099. doi: 10.1038/ncb2293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14(2):159–169. doi: 10.1016/j.devcel.2008.01.013. [DOI] [PubMed] [Google Scholar]
  • 54.Alessio N, Squillaro T, Cipollaro M, et al. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene. 2010;29(40):5452–5463. doi: 10.1038/onc.2010.285. [DOI] [PubMed] [Google Scholar]
  • 55.Isakoff MS, Sansam CG, Tamayo P, et al. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A. 2005;102(49):17745–17750. doi: 10.1073/pnas.0509014102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004;4(10):793–805. doi: 10.1038/nrc1455. [DOI] [PubMed] [Google Scholar]
  • 57.van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci. 1999;2(3):266–270. doi: 10.1038/6368. [DOI] [PubMed] [Google Scholar]
  • 58.Decristofaro MF, Betz BL, Rorie CJ, et al. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol. 2001;186(1):136–145. doi: 10.1002/1097-4652(200101)186:1<136::AID-JCP1010>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  • 59.Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394(6689):203–206. doi: 10.1038/28212. [DOI] [PubMed] [Google Scholar]
  • 60.Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene. 2009;28(14):1653–1668. doi: 10.1038/onc.2009.4. [DOI] [PubMed] [Google Scholar]
  • 61.Kippin TE, Martens DJ, van der Kooy D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev. 2005;19(6):756–767. doi: 10.1101/gad.1272305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Meletis K, Wirta V, Hede SM, et al. p53 suppresses the self-renewal of adult neural stem cells. Development. 2006;133(2):363–369. doi: 10.1242/dev.02208. [DOI] [PubMed] [Google Scholar]
  • 63.Gil-Perotin S, Haines JD, Kaur J, et al. Roles of p53 and p27(Kip1) in the regulation of neurogenesis in the murine adult subventricular zone. Eur J Neurosci. 2011;34(7):1040–1052. doi: 10.1111/j.1460-9568.2011.07836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Medrano S, Scrable H. Maintaining appearances--the role of p53 in adult neurogenesis. Biochem Biophys Res Commun. 2005;331(3):828–833. doi: 10.1016/j.bbrc.2005.03.194. [DOI] [PubMed] [Google Scholar]
  • 65.Tomasevic G, Shamloo M, Israeli D, et al. Activation of p53 and its target genes p21(WAF1/Cip1) and PAG608/Wig-1 in ischemic preconditioning. Brain Res Mol Brain Res. 1999;70(2):304–313. doi: 10.1016/s0169-328x(99)00146-1. [DOI] [PubMed] [Google Scholar]
  • 66.Ring RH, Valo Z, Gao C, et al. The Cdkn1a gene (p21Waf1/Cip1) is an inflammatory response gene in the mouse central nervous system. Neurosci Lett. 2003;350(2):73–76. doi: 10.1016/s0304-3940(03)00883-8. [DOI] [PubMed] [Google Scholar]
  • 67.Macleod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995;9(8):935–944. doi: 10.1101/gad.9.8.935. [DOI] [PubMed] [Google Scholar]
  • 68.Vasey DB, Wolf CR, MacArtney T, et al. p21-LacZ reporter mice reflect p53-dependent toxic insult. Toxicol Appl Pharmacol. 2008;227(3):440–450. doi: 10.1016/j.taap.2007.11.029. [DOI] [PubMed] [Google Scholar]
  • 69.Wu JI, Lessard J, Olave IA, et al. Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron. 2007;56(1):94–108. doi: 10.1016/j.neuron.2007.08.021. [DOI] [PubMed] [Google Scholar]
  • 70.Cameron HA, McKay RD. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol. 2001;435(4):406–417. doi: 10.1002/cne.1040. [DOI] [PubMed] [Google Scholar]
  • 71.Fischer TJ, Walker TL, Overall RW, et al. Acute effects of wheel running on adult hippocampal precursor cells in mice are not caused by changes in cell cycle length or S phase length. Front Neurosci. 2014;8:314. doi: 10.3389/fnins.2014.00314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Brown J, Cooper-Kuhn CM, Kempermann G, et al. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci. 2003;17(10):2042–2046. doi: 10.1046/j.1460-9568.2003.02647.x. [DOI] [PubMed] [Google Scholar]
  • 73.Ihrie RA, Alvarez-Buylla A. Lake-front property: a unique germinal niche by the lateral ventricles of the adult brain. Neuron. 2011;70(4):674–686. doi: 10.1016/j.neuron.2011.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Calzolari F, Michel J, Baumgart EV, et al. Fast clonal expansion and limited neural stem cell self-renewal in the adult subependymal zone. Nat Neurosci. 2015;18(4):490–492. doi: 10.1038/nn.3963. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp FigureS1-S3 & TableS1-S3
Supp MaterialS1

RESOURCES